Enochian Biosciences
moving forward summary of potential milestones submission | Enochian Biosciences
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
37 of 39
Related slides by other companies
AbCellera
Investor Conference
January 2024
advancing an internal pipeline of potential first in class and best in class assets is a top priority to drive growth first two submissions anticipated in we intend take additional development candidates into enabling studies in in non dilutive funding from governments canada atopic dermatitis or undisclosed | AbCellera
Other recent decks by Enochian Biosciences
See all presentations (3 decks)
Investor Presentation
January 2024
Results
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io